Interaction Study of Zanubrutinib With Moderate and Strong CYP3A Inhibitors in Participants With B-Cell Malignancies
BeiGene
BeiGene
Hutchmed
Ipsen
Medical College of Wisconsin
National Hospital for Tropical Diseases, Hanoi, Vietnam
Fred Hutchinson Cancer Center